Johnson & Johnson: J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold?
JNJ stock has surged 38% in six months on strong drug and MedTech growth, but patent losses and lawsuits loom. Is it still a hold?
Read full article »
Johnson & Johnson is a New Jersey-based firm that engages in research, manufacturing and sale of healthcare products including consumer, pharmaceutical and medical devices.
Read more